Both BRD7 and c-Myc are significantly upregulated in CRC patients, and the expression of BRD7 is positively associated with high levels of c-Myc protein; the high expression of these proteins indicates advanced clinical stage and poor prognosis in CRC patients. Here, MYC is linked to colorectal carcinoma.